AbbVie Inc. announced that its board of directors unanimously selected Mr. Gonzalez, who has served as CEO since AbbVie's formation in 2013, will become executive chairman of the board of directors, effective July 1, 2024. Additionally, the board has appointed Mr. Michael as a member of the board of directors effective July 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.4 USD | +1.26% | +3.53% | +7.39% |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
May. 17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.39% | 294B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B | |
-0.52% | 162B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Abbvie Inc. Announces Board Changes, Effective July 1, 2024